NanoViricides Inc NNVC Q1 2026 Earnings Narrower Loss Drives Positive Stock Reaction CNM Q1 2026 Earnings EPS Surpasses Estimates by Nearly 23 Fueled by Strong Demand in Water Infrastructure DRMA Q1 2026 Earnings Narrower Loss Than Expected Bolsters Investor Sentiment ALRS Q1 2026 Earnings EPS Beat by 4838 but Stock Declines 057 OCGN Q1 2026 Earnings WiderthanExpected Loss as Preclinical Pipeline Progress Continues SY Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue Uncertainty